Press Releases

;

Trump budget proposes over $1.5 billion cut to domestic HIV programs

Apr 3, 2026

Congress rejected these massive attacks on HIV prevention last year and we will urge them to do the same again this year. While we are reassured that over 600,000 low-income people currently accessing care and treatment through the Ryan White HIV/AIDS Program and those using PrEP programs in community health centers can maintain their services, the dismantling of HIV prevention and surveillance and other programs will just lead to more HIV infections and higher health costs down the road.

read more

Comprehensive national PrEP bills to prevent HIV introduced

Mar 4, 2026

We thank the leadership of Sens. Smith and Schiff and Reps. Takano, Balint and Pocan in reintroducing the PrEP Access and Coverage Act,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “Passage of this bill will greatly expand access to PrEP for people who have health coverage across all payers and create a national grant program that includes community and provider outreach as well as PrEP drugs and associated services for the uninsured. We have a national HIV treatment program, but in order to end HIV, we need a comprehensive national HIV PrEP program.

read more

Trump administration fails to take steps to lower patient costs for prescription drugs

Feb 9, 2026

In the 2027 Notice of Benefit and Payment Parameters rule proposed today, the administration failed to include promised new regulations on whether copay assistance will count towards patient cost-sharing. “Every day this rule is delayed is another day that insurers and PBMs are pocketing billions of dollars meant for patients who are struggling to afford their drugs,” commented Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We know that President Trump is squarely focused on drug affordability, and while we are extremely disappointed that this simple step was not yet taken, we urge the administration to act in the very near future.”

read more

TrumpRx Shakes Up Drug Pricing by Bypassing Middlemen

Feb 5, 2026

Today marks a monumental step in transforming drug pricing and making prescription drugs more affordable for the American people, particularly for those without insurance. For those who do have insurance, TrumpRx may not always be the best option. We hope consumers clearly understand this and urge the Trump administration to expand the site and work with insurers so that TrumpRx payments are counted by insurers. Frankly, if people who have health insurance are using TrumpRx, it demonstrates that the insurer is failing to meet the needs of its paying consumers.

read more

HIV+Hep praises DC for protecting PrEP access

Feb 3, 2026

Thanks to the leadership of Councilmembers Zachary Parker and Christina Henderson, DC residents who are at risk of HIV will be able to access all forms of PrEP without cost-sharing or prior authorization. This is particularly important since federal preventive health requirements have recently come under attack. We are especially grateful for the amendment to the bill that will require insurers to cover all PrEP drugs, including new long-acting regimens.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest